 |
 |
 |
 |
Bookmark Health Information
Make Health Information Your Homepage
|
 |
|
Herbal Medicine
GREEN HELLEBORE (Helleborus viridis L.) X
Activities (Green Hellebore) : Bradycardic (1; HHB); Cardiac (f; EFS); Diuretic (f; PH2); Emetic (1; HHB); Emmenagogue (f; EFS); Irritant (1; PH2); Laxative (1; HHB); Nervine (f; EFS); Poison (1; HHB); Ptarmic ( = mucoirritant) (1; PH2); Respiraparalytic (1; HHB); Sialagogue (1; PH2); Sternutator (f; EFS); Toxic (f; EFS); Vermifuge (f; HHB).
Indications (Green Hellebore) : Cancer (f; JLH); Cancer, spleen (f; JLH); Constipation (1; HHB; PH2); Diarrhea (f; PH2); Induration (f; JLH); Nausea (f; PH2); Neurosis (f; HHB); Splenosis (f; HHB); Wart (f; JLH); Water Retention (f; PH2); Worm (f; HHB).
Dosages (Green Hellebore) : 600 mg root, maximum daily dose 1200 mg (HHB); 200 mg single dose, maximum 1000 mg (PH2).
Contraindications, Interactions, and Side Effects (Green Hellebore) : Not covered (AHP). Do not take it (JAD). Overdoses may cause asphyxiation, following cardiac arrhythmia, convulsions, diarrhea, dizziness, dyspnea, and nausea (PH2).
GROUND PINE, YELLOW BUGLE (Ajuga chamaepitys (L.) Schreb.) ++
Synonym : Teucrium chamaepitys L.
Activities (Ground Pine) : Diaphoretic (f; EFS); Diuretic (f; EFS; PH2); Emmenagogue (f; EFS; PH2); Stimulant (f; PH2); Tonic (f; EFS); Vulnerary (f; EFS).
Indications (Ground Pine) : Ague (f; GMH); Cancer (f; JLH); Cirrhosis (f; JLH); Dropsy (f; GMH); Fever (f; EFS); Gout (f; GMH; PH2); Gynecopathy (f; GMH; PH2); Hepatosis (f; JLH); Induration (f; JLH); Jaundice (f; GMH); Mastosis (f; JLH); Rheumatism (f; GMH; PH2); Splenosis (f; JLH); Swelling (f; JLH); Water Retention (f; EFS; PH2).
Dosages (Ground Pine) : 1 tbsp decoction (1 oz dry herb/pint boiling water) several ×/day (GMH).
Contraindications, Interactions, and Side Effects (Ground Pine) : Not covered (AHP; KOM). Hazards and/or side effects not known for proper therapeutic dosages (PH2) (but PH2 designates no specific quantified dosage! JAD).
Hit: 382
Print
Health Information Homepage
| |
|
 |
 |
 |
 |